← Eichor
Study identifier: NCT06687018 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Kaltenborn and Mulligan Mobilisation in Patients With Carpal Tunnel Syndrome.

Condition: Carpal Tunnel Syndrome (CTS)  ·  Sponsor: Riphah International University

PhaseNA
Planned participants48
Who can joinAll sexes, 20 Years to 45 Years
Healthy volunteersNo

About this study

Carpal Tunnel Syndrome is the most common mononeuropathy that results from the compression of median nerve in carpal tunnel, leading to entrapment neuropathy. The symptoms become aggravated during drawing, typing or playing video games. The aim of study will be to compare the effects of Kaltenborn and Mulligan mobilisation on pain, disability and hand function in patients with carpal tunnel syndrome.

This description comes directly from the study's public registry record.

Talk to the study team

Imran Amjad, Phd  ·  03324390125  ·  Imran.amjad@riphah.edu.pk

Imran Amjad, Phd  ·  051-5481826  ·  Imran.amjad@riphah.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Ejaz HospitalLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06687018